Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

San Francisco Start-up SynerGI Introduces a Breakthrough New Product, The Colon Vitamin, with Ingredients Shown to Prevent the Formation of Polyps
  • USA - English


News provided by

The Colon Vitamin

Feb 27, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

The Colon Vitamin With Superfood Curcumin - For Optimal Colon Health
The Colon Vitamin With Superfood Curcumin - For Optimal Colon Health

I developed The Colon Vitamin in response to queries from my patients,” shared Dr. Farrell. “It occurred to me that a product containing all the appropriate micronutrients and antioxidants in the right dosages would be more convenient & effective.

Post this

San Francisco, CA (PRWEB) February 27, 2014 -- To coincide with the Colon Cancer Awareness month of March, SynerGI, Inc. launches The Colon Vitamin™, a dietary supplement to promote optimal colon health. The Colon Vitamin™ was developed by Dr. Frank Farrell, a board-certified gastroenterologist committed to colon cancer prevention. The Colon Vitamin™ contains micronutrients and antioxidants shown in scientific studies to prevent the formation of polyps or reduce the risk of colon cancer. Taken in two tablets, the first targets the small intestine, and the second targets the colon, where a breakthrough patent-pending delivery mechanism releases calcium. The calcium, at a carefully calibrated pH level, binds with fatty acids and bile acids, which may inhibit polyp formation. This unique delivery system is key to providing calcium directly to the colon, bypassing the stomach and small intestine. See video on how it works.

“I developed The Colon Vitamin™ in response to queries from my patients,” shared Dr. Farrell. “After a colonoscopy, many asked what they could do to prevent the formation of polyps. I would recommend a high-fiber diet, exercise, and various micronutrients like calcium and vitamin D. It occurred to me to look into providing a product that contained the appropriate micronutrients and antioxidants. Further research led me to developing the unique delivery mechanism for calcium.” See video.

Colorectal cancer is the second leading cause of cancer-related deaths in the United States for men and women combined, and the leading cause of cancer-related deaths among non-smokers. It is also the most preventable cancer. In 2014, the American Cancer Society expects 50,310 deaths from colorectal cancer, and estimates 96,830 new cases of colon cancer and 40,000 new cases of rectal cancer. The lifetime risk of developing colorectal cancer is about 1 in 20, or 5%.

Colonoscopy helps identify colorectal cancer at early stages when it is at its easiest and least expensive stage to treat and when the possibility of cure is the greatest.
It is the primary method of detecting and removing precancerous polyps (abnormal growths in the lining of the colon), and thus eliminating the possibility that they progress to cancer. To encourage more people to get screened, the Affordable Care Act (ACA) is removing cost barriers to individuals by requiring private health insurers to cover colonoscopy screenings without any patient cost-sharing, such as copays and deductibles. Regular colonoscopies can also help decrease the $12.2 billion spent each year in the U.S. on colorectal cancer treatment (annual cost for advanced cases exceed $300,000).

“Colon cancer is preventable and taking a proactive approach to colon health is something we all can do every day to reduce our risk,” said Eric Hargis, CEO, Colon Cancer Alliance. “It is important that everyone over the age of 50 and those who are younger with risk factors get screened.”

To complement these vital regular screenings, consumers can take The Colon Vitamin which is widely available and reasonably-priced. The Colon Vitamin’s™ micronutrients and antioxidants have been shown to prevent the formation of polyps or reduce the risk of cancer. Each ingredient is backed by scientific research, and includes beta-carotene, Vitamin D, Vitamin B2, Vitamin B6, folic acid (folate), calcium, selenium, and curcumin from the superfood turmeric.

The Colon Vitamin™ is for everyone who is concerned about their colon health, has a history of colon polyps, or has a family history of colon polyps or cancer. People with these risk factors may also benefit from The Colon Vitamin™:

• anyone over 50 (9 out of 10 diagnosed with colorectal cancer is at least 50)
• African Americans (highest colorectal cancer incidence of all racial groups in U.S.)
• Jews of Eastern European descent
• people with Type 2 diabetes

“We can no longer await on a cure for colon cancer; prevention is the key,” explained Georgia Hurst, Founder of ihavelynchsyndrome.com. “The Colon Vitamin™ is one in the constellation of factors that could help improve colon health.”

In a recent survey, 94% of gastroenterologists would recommend a supplement with the ingredients contained in The Colon Vitamin™ to their patients with a history of colon polyps. A vast majority felt it was important that such a vitamin supplement be developed with sound scientific backing. Samples of The Colon Vitamin™ are available at Endoscopy Centers and Ambulatory Surgery Centers (ASCs) where colonoscopies are performed.

Availability & Pricing
The Colon Vitamin™ is sold online at TheColonVitamin.com, Amazon, and at pharmacies and drugstores.

About The Colon Vitamin™
The Colon Vitamin™ is a physician-developed daily supplement that contains ingredients shown in scientific studies to help prevent the formation of colon polyps or reduce the risk of colon cancer. The makers of The Colon Vitamin™are committed to colon cancer prevention, and a percentage of profits will go toward doctor training and advancing colon cancer research. More information is available at TheColonVitamin.com.

Media Contact
Aireen de Peralta
Chief Marketing Officer
Aireen(at)TheColonVitamin(dot)com
(415) 713-5783

Copyright © 2014. All Rights Reserved. The Colon Vitamin™ is a trademark of SynerGI®, Inc. Other company and product names may be trademarks of their respective companies. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Aireen De Peralta, The Colon Vitamin, http://thecolonvitamin.com/, +1 415-713-5783, [email protected]

Modal title

Dr. Frank Farrell, Creator of The Colon Vitamin
Dr. Frank Farrell, Creator of The Colon Vitamin
The Colon Vitamin - For Optimal Colon Health
The Colon Vitamin - For Optimal Colon Health
Dr. Frank Farrell, Creator of The Colon Vitamin The Colon Vitamin - For Optimal Colon Health

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.